LONDON BROKER RATINGS: Barclays cuts WPP to 'underweight'
25th Jun 2025 09:33
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
| Price | 223.50p on 02-07-2025 at 18:50:08 |
|---|---|
| Change | -3.50p -1.54% |
| Buy | 224.00p |
| Sell | 223.50p |
| Buy / Sell SPI Shares | |
| Last Trade: | Buy 5,665.00 at 223.497p |
| Day's Volume: | 389,423 |
| Last Close: | 223.50p |
| Open: | 226.50p |
| ISIN: | GB00BNLPYF73 |
| Day's Range | 221.50p - 227.50p |
| 52wk Range: | 168.20p - 263.00p |
| Market Capitalisation: | £899m |
| VWAP: | 223.84884p |
| Shares in Issue: | 402m |
Spire Healthcare (SPI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 5,665 | 223.497p | SI Trade Negotiated Trade |
16:47:03 - 02-Jul-25 |
| Buy* | 185,551 | 223.50p | Suspected BUY Trade |
16:35:10 - 02-Jul-25 |
| Sell* | 2 | 223.50p | Automatic Execution |
16:29:56 - 02-Jul-25 |
| Sell* | 17 | 223.50p | Automatic Execution |
16:29:54 - 02-Jul-25 |
| Sell* | 30 | 223.50p | Automatic Execution |
16:29:54 - 02-Jul-25 |
| Sell* | 5 | 223.50p | Ordinary |
16:29:41 - 02-Jul-25 |
| Buy* | 1 | 224.00p | SI Trade |
16:29:07 - 02-Jul-25 |
| Buy* | 3 | 224.00p | SI Trade |
16:28:26 - 02-Jul-25 |
| Sell* | 45 | 223.50p | SI Trade |
16:28:07 - 02-Jul-25 |
| Sell* | 692 | 223.6212p | Ordinary |
16:27:52 - 02-Jul-25 |
Spire Healthcare (SPI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 24th Jun 2025 11:30 am | RNS | Director/PDMR Shareholding |
| 23rd Jun 2025 4:07 pm | RNS | Holding(s) in Company |
| 4th Jun 2025 5:33 pm | RNS | Holding(s) in Company |
| 14th May 2025 3:23 pm | RNS | Result of AGM |
| 14th May 2025 7:00 am | RNS | AGM Trading Statement |
| 10th Apr 2025 3:20 pm | RNS | Director/PDMR Shareholding |
| 8th Apr 2025 12:30 pm | RNS | Annual Financial Report |
| 1st Apr 2025 7:00 am | RNS | Acquisition of Acorn Occupational Health Limited |
| 31st Mar 2025 12:16 pm | RNS | Block listing Interim Review |
| 28th Mar 2025 1:09 pm | RNS | Director/PDMR Shareholding |